Skip to content
value.today

AbbVie Inc. vs Pfizer Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • AbbVie Inc. is the larger company by market value: $514.0 B against $170.7 B for Pfizer Inc., 3.0 times as much (market caps of Oct 30, 2026).
  • Pfizer Inc. had more revenue: $62.6 B against $61.2 B for AbbVie Inc., both in the year to December 2025.
  • Pfizer Inc. earned more: net income of $7.8 B against $4.2 B for AbbVie Inc.
  • Pfizer Inc. keeps more of each dollar of sales: a net margin of 12.4% against 6.9% for AbbVie Inc.
  • Pfizer Inc. employs more people: 75,000 against 57,000 at AbbVie Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $834,387 at Pfizer Inc.
  • On price to earnings, AbbVie Inc. trades at 49.7× and Pfizer Inc. at 42.3×: investors pay more for each dollar of AbbVie Inc.'s profit.
  • AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -1.6% for Pfizer Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and Pfizer Inc. 5.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0981952933902020202120222023202420252026AbbVie Inc. 390Pfizer Inc. 79

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$25B$51B$76B$101B201720182019202020212022202320242025AbbVie Inc. $61BPfizer Inc. $63B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbVie Inc.
ABBV · #27 in the world
Pfizer Inc.
PFE · #127 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded20131849
Size
Market cap$514.0 B$170.7 B
Revenue$61.2 B$62.6 B
Net income$4.2 B$7.8 B▲ best
Employees57,00075,000
Valuation
P/E ratio49.7×42.3×
Price to sales7.8×2.7×
Price to book—2.0×
Free cash flow yield3.5%5.3%▲ best
Profitability
Gross margin70.2%74.3%▲ best
Operating margin24.6%—
Net margin6.9%12.4%▲ best
Return on equity—8.9%
Return on invested capital16.0%—
Growth
Revenue growth8.6%▲ best-1.6%
Revenue growth, 3 years a year1.8%▲ best-14.8%
Earnings per share growth-1.3%▲ best-3.5%
Financial strength
Debt to equity—0.7×
Interest cover5.2×—
Cash
Free cash flow margin29.1%▲ best14.5%
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.5%—
Strength scores
Piotroski F-score8 of 9▲ best5 of 9
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, AbbVie Inc. or Pfizer Inc.?

AbbVie Inc. is the larger company by market value: $514.0 B against $170.7 B for Pfizer Inc., 3.0 times as much (market caps of Oct 30, 2026).

Which makes more money, AbbVie Inc. or Pfizer Inc.?

Pfizer Inc. had more revenue: $62.6 B against $61.2 B for AbbVie Inc., both in the year to December 2025. Pfizer Inc. earned more: net income of $7.8 B against $4.2 B for AbbVie Inc.

Which is more profitable, AbbVie Inc. or Pfizer Inc.?

Pfizer Inc. keeps more of each dollar of sales: a net margin of 12.4% against 6.9% for AbbVie Inc.

Which has more employees, AbbVie Inc. or Pfizer Inc.?

Pfizer Inc. employs more people: 75,000 against 57,000 at AbbVie Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $834,387 at Pfizer Inc.

Is AbbVie Inc. cheaper than Pfizer Inc.?

On price to earnings, AbbVie Inc. trades at 49.7× and Pfizer Inc. at 42.3×: investors pay more for each dollar of AbbVie Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Which is growing faster, AbbVie Inc. or Pfizer Inc.?

AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -1.6% for Pfizer Inc.

Which is financially stronger, AbbVie Inc. or Pfizer Inc.?

On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and Pfizer Inc. 5.